Jan 24 (Reuters) - Aviragen Therapeutics Inc:
* CAS GROUP DELIVERS LETTER TO THE STOCKHOLDERS OF AVIRAGEN
* CAS GROUP SAYS PROPOSED MERGER BETWEEN AVIRAGEN AND VAXART NOT IN BEST INTERESTS OF STOCKHOLDERS OF AVIRAGEN
* CAS GROUP - “BELIEVE VAXART’S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER”
* CAS GROUP SAYS “‍BELIEVE VAXART’S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER AND THAT VAXART IS NOT READY TO BE A PUBLIC COMPANY”​
* CAS GROUP - DIGIRAD CORP, EAST HILL MANAGEMENT, THOMAS CLAY (COLLECTIVELY CAS GROUP) OWN ABOUT 8.3 PERCENT OF OUTSTANDING AVIRAGEN SHARES
* CAS GROUP - HAS NOMINATED A SLATE OF DIRECTORS FOR AVIRAGEN’S BOARD Source text for Eikon: Further company coverage:
